Consulting Services for Private Equity/Venture Capital Firms
Commercial Due Diligence
Commercial due diligence covering market dynamics, price-volume trends, market growth, key purchase criteria, competitive positioning of target company and product portfolio, review of management business plan and growth strategy.
We have successfully executed commercial due diligence in following healthcare segments:
Medical devices and equipment
Pharma CDMOs and CROs
MedTech contract manufacturing
Healthcare IT
Specialty Pharmaceuticals
Branded and unbranded generics
We also offer early due diligence services to enable our Private Equity clients to make go, no-go decisions in a timely and cost-effective manner.
Our client was looking to invest in a family-owned pharma CDMO. They engaged with us to leverage our deep expertise in this area and in order to guide them through their investment decision process.
Our approach
In addition to analyzing the market dynamics, growth, we conducted a deep dive (during 2-3 weeks) into:
Customer dependency and potential risks
Current commercial contract analysis
Sources of differentiation versus key competitors
Detailed analysis of management budget and commercial plan
Potential M&A opportunities
Customer referencing
Results
Our client could leverage our research with their investment committee and successfully negotiate an agreement with the seller, taking into consideration they key risks and opportunities
Quick Enquiry For
121/7E Avenue Franklin Roosevelt 1050 Brussels, Belgium
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
